ScholarIQanswers from OpenAlex & ORCID
Vlado Perkovic
ResearcherPublications, citations & collaboration network
Vlado Perkovic is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vlado Perkovic have?
ScholarIQindexed works
Vlado Perkovic has 775 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vlado Perkovic have?
ScholarIQcitation count
Vlado Perkovic has 65,478 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vlado Perkovic?
ScholarIQh-index
Vlado Perkovic has an h-index of 120 in OpenAlex.
What is the i10-index of Vlado Perkovic?
ScholarIQi10-index
Vlado Perkovic has an i10-index of 363 in OpenAlex.
What is the ORCID of Vlado Perkovic?
ScholarIQorcid
The ORCID for Vlado Perkovic is on the source record.
What is the OpenAlex record for Vlado Perkovic?
ScholarIQopenalex
The OpenAlex for Vlado Perkovic is on the source record.
What are the most-cited papers on Vlado Perkovic?
ScholarIQmost cited works
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R. Matthews
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
Worldwide access to treatment for end-stage kidney disease: a systematic review
Thaminda Liyanage, Toshiharu Ninomiya, Vivekanand Jha, Bruce Neal, Halle Marie Patrice, Ikechi G. Okpechi, Ming‐Hui Zhao, Jicheng Lv, Amit X. Garg, John Knight, Anthony Rodgers, Martin Gallagher, Sradha Kotwal, Alan Cass, Vlado Perkovic
Chronic kidney disease
Kamyar Kalantar‐Zadeh, Tazeen H. Jafar, Dorothea Nitsch, Brendon L. Neuen, Vlado Perkovic
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Michael Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, Hans J. Woerle, David Baanstra, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, for the CARMELINA Investigators